GnuBIO

About:

GnuBIO is a developer of scalable DNA sequencing technology for the diagnostic and applied markets.

Website: http://gnubio.com

Description:

GnuBIO is a developer of scalable DNA sequencing technology for both the Diagnostic and Applied markets. The GnuBIO technology is an emulsion-based microfluidic technology, which provides a scalable desktop sequencing system that allows interrogation of single genes, gene panels, and whole genomes. Using a proprietary DNA sequencing system, the GnuBIO’s platform encompasses all the steps required for DNA sequencing into a single platform including target selection and enrichment, DNA amplification, DNA sequencing and analysis. GnuBIO’s cutting-edge platform provides a single user interface, and a single step process, which rapidly produces results to hours versus days.

Total Funding Amount:

$22.5M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2009-01-01

Contact Email:

info(AT)gnubio.com

Founders:

John Boyce

Number of Employees:

11-50

Last Funding Date:

2012-10-02

IPO Status:

Private

Industries:

© 2025 bioDAO.ai